AzTrials
AzTrials

StrokeNCT04813120

Digital Mirror Therapy With Uni- and Bilateral Mirror Visual Feedback After Stroke: Treatment Effects and EEG Evidence

A study testing Uni-MVF condition and unimanual training mode using the new MT system (UM-UT), Uni-MVF condition and bimanual training mode using the new MT system (UM-BT) and Bi-MVF condition and bimanual training mode using the new MT system (BM-BT) in people with Stroke and Cerebrovascular Disorders, run by Chang Gung Memorial Hospital at 2 sites in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The specific study aims will be: 1. To examine the treatment effects of a new digital mirror therapy (MT) system versus a mirror box in patients with stroke by conducting a 4-group randomized controlled trial. 2. Read more about this study

Who is it for?
Ages 20 to 80 years
What is being tested?
Uni-MVF condition and unimanual training mode using the new MT system (UM-UT), Uni-MVF condition and bimanual training mode using the new MT system (UM-BT) and Bi-MVF condition and bimanual training mode using the new MT system (BM-BT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
47 participants
Where
2 sitesTaiwan
Study dates
1 Aug 2021to 31 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • diagnosed with a unilateral stroke;
  • at least 6 months after stroke onset;
  • age between 20 and 80 years old;
  • having a baseline score of Fugl-Meyer Assessment (FMA) in a range of 20 to 60;
  • able to follow the study instructions;
  • capable of participating in therapy and assessment sessions
Show all 12Show fewer
  • diagnosed with a unilateral stroke;
  • at least 2 weeks after stroke onset and medical stable;
  • aged 20 to 80 years;
  • having a baseline score of FMA ≥ 40 and wrist flexion ≥ 20 degrees in order to perform EEG motor tasks;
  • both wrist flexion and extension scores of Modified Ashworth Scale ≤ 1;
  • able to follow the study instructions

Who cannot join

  • global or receptive aphasia;
  • severe neglect measured by line bisection test;
  • other major medical diseases or comorbidities that have influenced upper-limb usage or caused severe pain
  • Part II: Investigation of the Electrophysiological Mechanisms Underlying Different MVF Conditions by EEG
  • global or receptive aphasia;
  • severe neglect measured by line bisection test;
  • other major medical diseases or comorbidities, such as neurological and psychiatric diseases, that have caused severe pain of upper-limb or interfered brain neural activities

Trial locations and contacts

2 sites in 1 country.

Taiwan2 sites
  • Lo-Sheng Sanatorium and Hospital

    Taoyuan City, Taoyuan, 333

  • Taoyuan Chang Gung Memorial Hospital

    Taoyuan City, 333

Other trials in Taiwan

About this study

Official title: The Use of a New Digital Mirror Therapy System Providing Unilateral and Bilateral Mirror Visual Feedback for Patients With Stroke: Treatment Effects and EEG-physiological Evidence

The specific study aims will be:

  1. To examine the treatment effects of a new digital mirror therapy (MT) system versus a mirror box in patients with stroke by conducting a 4-group randomized controlled trial.
  2. To examine the electrophysiological mechanisms of uni-mirror visual feedback (uni-MVF) condition with unimanual training mode, uni-MVF condition with bimanual training mode, and bi-MVF condition with bimanual training mode in the new MT system by EEG.
Read the detailed description

Part I: Validation of Treatment Efficacy of the New Digital MT System with Different MVF Conditions and Training Modes

In this new MT system, 3 different types of MT in different MVF conditions and training modes can be provided: unilateral MVF with unimanual training mode (UM-UT), unilateral MVF with bimanual training mode (UM-BT), and bilateral MVF with bimanual training mode (BM-BT). In the part Ⅰ study, an estimated total of 80 patients with stroke will be recruited. In addition to the original rehabilitation interventions of patients, each participant will be randomly allocated to 1 of 4 intervention groups (i.e., UM-UT, UM-BT, BM-BT, or traditional MT using a mirror box) for 15-hour therapy sessions. Outcome measures will be administrated at pre-treatment, immediately after treatment, and at 1-month follow-up after treatment.

Part II: Investigation of the Electrophysiological Mechanisms Underlying Different MVF Conditions by EEG

Twenty stroke patients will be recruited for examining the brain electrophysiological mechanisms underlying different types of MVF and training conditions of this new system by using electroencephalography (EEG). Three experimental conditions, including UM-UT, UM-BT, and BM-BT conditions, will be conducted in the EEG study.

Being tested
Uni-MVF condition and unimanual training mode using the new MT system (UM-UT), Uni-MVF condition and bimanual training mode using the new MT system (UM-BT), Bi-MVF condition and bimanual training mode using the new MT system (BM-BT), Traditional MT using a mirror box
Keywords
digital rehabilitation, cerebrovascular accident, mirror visual feedback, brain electrophysiology
Medical subject headings
Stroke, Cerebrovascular Disorders, Central Nervous System Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Uni-MVF condition and unimanual training mode using the new MT system (UM-UT)Behavioural

    For the UM-UT group, the participants will be seated in front of the new MT system, and will be instructed to watch the real-time image reflection of movements of the non-affected arm and hand on the screen carefully. At the same time, the patients will need to imagine that the movements were performed by their affected arm and hand. In this group, only the non-affected arm and hand will need to perform the movements, but the affected one will not need to move.

  • Uni-MVF condition and bimanual training mode using the new MT system (UM-BT)Behavioural

    During the UM-BT, as similar as the first group (UM-UT), the participants will be also seated in front of the new MT system, and be instructed to watch the real-time image reflection of the non-affected arm and hand's movements on the screen carefully and imagine that the movements were performed by the affected arm. However, in this UM-BT group, the bilateral training mode is emphasized, and thus both arms and hands will need to move. That is, during therapy, the patient's affected arm and hand will be required to move at his/her best motor ability with the non-affected arm and hand at the same time.

  • Bi-MVF condition and bimanual training mode using the new MT system (BM-BT)Behavioural

    For the BM-BT group, the participants will be seated in front of this new MT system, and be instructed to observe the real-time image reflection of the non-affected arm and hand's movements transformed and superimposed on both arms and hands (i.e., bi-MVF), and to imagine that the movements were performed by both arms and hands. In this group, bi-MVF and bilateral training mode are emphasized, and thus both arms and hands will also need to move. The patient's affected arm and hand will be required to move as could as possible simultaneously.

  • Traditional MT using a mirror boxBehavioural

    During traditional MT, the participants will be seated in front of a mirror box placed at their mid-sagittal plane. The affected arm and hand of the participants will be placed inside the mirror box, and the non-affected arm and hand will be in front of the mirror. As similar to the UM-UT group, the participants will be instructed to watch the mirror reflection of the movements performed by the non-affected arm and hand carefully and to imagine that the movements were performed by the affected arm and hand. In this group, the patient's affected arm and hand inside the mirror box will not need to move.

Study groups in NCT04813120
Study groupRoleWhat they receive
Uni-MVF condition and unimanual training mode using the new MT system (UM-UT)ExperimentalThe following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
Receives: Behavioral: Uni-MVF condition and unimanual training mode using the new MT system (UM-UT)
Uni-MVF condition and bimanual training mode using the new MT system (UM-BT)ExperimentalThe following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
Receives: Behavioral: Uni-MVF condition and bimanual training mode using the new MT system (UM-BT)
Bi-MVF condition and bimanual training mode using the new MT system (BM-BT)ExperimentalThe following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
Receives: Behavioral: Bi-MVF condition and bimanual training mode using the new MT system (BM-BT)
Traditional MT using a mirror boxActive comparatorThe following common categories of upper-limb movements and actions will be selected and included in this group: (a) active range of motion (AROM) exercises, (b) reaching movements, and (c) object manipulation.
Receives: Behavioral: Traditional MT using a mirror box

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change scores of Fugl-Meyer Assessment

    The upper-limb subsection of Fugl-Meyer Assessment is a measure with sound psychometric properties to evaluate motor impairments.

    Measured: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)

  2. Change scores of Chedoke Arm and Hand Activity Inventory

    The Chedoke Arm and Hand Activity Inventory is a reliable and validated measure to assess the independence of stroke patients to perform activities of daily living with an affected upper limb.

    Measured: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)

Secondary outcomes (7)
  1. change scores of Box and Block Test

    The Box and Block Test is a tool with sound reliability and validity to evaluate hand dexterity of stroke patients.

    Measured: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)

  2. change scores of Revised Nottingham Sensory Assessment

    The Revised Nottingham Sensory Assessment is a standardized measure with good reliability to assess sensory function in patients with stroke.

    Measured: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)

  3. change scores of Movement Imagery Questionnaire-Revised, Second Edition

    The Movement Imagery Questionnaire-Revised, Second Edition is a 14-item questionnaire with sound reliability and validity to evaluate the ability of motion imagination in patients with stroke.

    Measured: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)

  4. change scores of Barthel Index

    The Barthel Index is a validated tool designed to measure activities reflecting the daily living independence.

    Measured: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)

  5. change scores of Motor Activity Log

    The Motor Activity Log is a semi-structured interview with good psychometric properties to assess the level of use of affected upper limb in 30 main activities of daily living.

    Measured: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)

  6. change scores of the health state of EQ-5D-5L

    The questionnaire of EQ-5D-5L contains 5 dimensions, including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, and uses a 5-point Likert scale scored from 1 (no problem) to 5 (unable to/extreme problems); whereas, the numerical description of 5 dimensions represents the health state.

    Measured: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)

  7. change scores of the visual analogue scale (VAS) of EQ-5D-5L

    The VAS of EQ-5D-5L scores will be scored from 0 to 100, with a higher score indicating better overall current health.

    Measured: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2021
  2. Study start1 Aug 2021
  3. Primary completion31 Jul 2024
  4. Study completion31 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
47 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04813120
Sponsor's protocol ID
202002234A3
Status last verified
Aug 2023
First submitted
21 Mar 2021
Last updated
21 Aug 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Uni-MVF condition and unimanual training mode using the new MT system (UM-UT), Uni-MVF condition and bimanual training mode using the new MT system (UM-BT) and Bi-MVF condition and bimanual training mode using the new MT system (BM-BT) in people with Stroke and Cerebrovascular Disorders, run by Chang Gung Memorial Hospital at 2 sites in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change scores of Fugl-Meyer Assessment (time frame: baseline (T0), at the end of 4 weeks of intervention (T1) , and 1 month after intervention (T2)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT04813120 | AzTrials